Original language | English |
---|---|
Pages (from-to) | 246-248 |
Number of pages | 3 |
Journal | British Journal of Dermatology |
Volume | 189 |
Issue number | 2 |
DOIs | |
Publication status | Published - Aug 2023 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: British Journal of Dermatology, Vol. 189, No. 2, 08.2023, p. 246-248.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Electronic screening for mental illness in patients with psoriasis
AU - Bechman, Katie
AU - Hayes, Joseph F.
AU - Mathewman, Julian
AU - Henderson, Alasdair D.
AU - Adesanya, Elizabeth I.
AU - Mansfield, Kathryn E.
AU - Smith, Catherine H.
AU - Galloway, James
AU - Langan, Sinéad M.
N1 - Funding Information: Conflicts of interest K.B. has received funding from Versus Arthritis and Pfizer Global Medical Grants for Quality Improvement in Rheumatology Practice. J.F.H. has received consultancy fees from Wellcome Trust and juli Health. K.M. declares consultancy fees from Amgen. C.H.S. is principal investigator on MRC (PSORT) and EC-funded consortia with multiple industry partners (see PSORT.org.uk, BIOMAP-IMI.eu, and HIPPOCRATES-IMI.eu for up-to-date listings of contributory partners), and is a co-supervisor of PhD studentships through MRC/industry collaboration (Boehringer Ingelheim GmbH). C.H.S. and S.M.L. have received grants from the Horizon 2020 European Commission-funded consortium, which has industry partners involved in the manufacture of treatments for immune-mediated inflammatory diseases (see the Biomap website for a complete listing). J.G. has received honoraria from AbbVie, Galapagos, Janssen, Lilly, Novartis, Pfizer and UCB. All other authors declare no competing interests. Funding Information: K.B. is funded by the National Institute for Health and Care Research (NIHR) Clinical Lectureship Programme. This study is funded by the NIHR Research for Patient Benefit programme (reference: PB-PG-0418-20025). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. J.F.H. is supported by UKRI grant MR/V023373/1, the University College London Hospitals NIHR Biomedical Research Centre and the NIHR North Thames Applied Research Collaboration. C.H.S. acknowledges support for this research from the NIHR Biomedical Research Centre at King's College London and Guy's and St Thomas' NHS Foundation Trust and the Psoriasis Association. S.M.L. is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (205039/Z/16/Z). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funders. S.M.L. is an investigator on the European Union Horizon 2020-funded BIOMAP Consortium ( http://www.biomap-imi.eu/ ). Funders had no role in the study design, collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication. This research was funded in whole or in part by the Wellcome Trust (G205039/Z/16/Z). For the purpose of Open Access, the author has applied a Creative Commons BY public copyright licence to any author accepted manuscript version arising from this submission.
PY - 2023/8
Y1 - 2023/8
UR - http://www.scopus.com/inward/record.url?scp=85165223614&partnerID=8YFLogxK
U2 - 10.1093/bjd/ljad141
DO - 10.1093/bjd/ljad141
M3 - Letter
C2 - 37224480
AN - SCOPUS:85165223614
SN - 0007-0963
VL - 189
SP - 246
EP - 248
JO - British Journal of Dermatology
JF - British Journal of Dermatology
IS - 2
ER -